Related Experiment Videos
Pathogenesis of hypertrophic cardiomyopathy: another viewpoint
1Institute of Cardiology, New Civil Hospital, Ahmedabad, India.
Insights
Genetic errors in handling catecholamines are unlikely to cause hypertrophic cardiomyopathy. Myocardial growth abnormalities, not catecholamine metabolism, are the probable cause of this heart condition.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Genetic factors are implicated in HCM development.
- A previous hypothesis suggested a role for catecholamine metabolism errors.
Purpose of the Study:
- To critically appraise the evidence linking catecholamines to hypertrophic cardiomyopathy pathogenesis.
- To identify more likely causes of HCM.
Main Methods:
- Literature review and critical appraisal of existing experimental and clinical studies.
- Analysis of genetic and molecular mechanisms involved in myocardial growth.
Main Results:
- Limited experimental or clinical evidence supports the role of catecholamines in HCM.
- Evidence suggests that abnormal myocardial growth is a more significant factor.
- Potential causes include excessive growth factors or genetic abnormalities in growth factor response.
Conclusions:
- The hypothesis of catecholamine handling errors causing HCM is not well-supported by current evidence.
- Abnormalities in myocardial growth regulation are the likely underlying cause of hypertrophic cardiomyopathy.
- Future research should focus on genetic and molecular pathways of cardiac growth.
Abstract:
A genetically determined error in the handling of catecholamines by the developing heart has been speculated to cause hypertrophic cardiomyopathy. A critical appraisal of the published literature reveals that there is little actual experimental or clinical evidence favouring the role of catecholamines in the pathogenesis of hypertrophic cardiomyopathy. Other factors seem to be more important. An abnormality of myocardial growth, either induced by excessive growth promoting substance, or a genetically determined abnormality in myocardial responses to normal growth factors during life (but not in the fetal handling of catecholamines) is likely to be responsible for hypertrophic cardiomyopathy.